The existing dogma is that α‐PD‐1 and α‐PD‐L1 antibodies protect PD‐1+ antitumor T cells from inhibition by tumor surface PD‐L1,10 but many mechanistic details of PD‐L1/PD‐1 signaling remain incompletely understood. Here, CD274 is linked to neoplasm.